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The radioprotective effects of 6 Gui-Pi-Wan extracts were investigated by examining cell viability and 30-d survival of mice after 
total-body 60Co irradiation. Pretreatment with Gui-Pi-Wan precipitate by water extraction and alcohol precipitation (PWA) prior 
to irradiation resulted in significantly higher cell survival and lower apoptosis rates at 24 h after 5 Gy radiation, and increased 
30-d survival in mice after exposure to a potentially lethal dose of 8 Gy. These results collectively indicate that PWA of 
Gui-Pi-Wan extracts is an effective radioprotective agent. 
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The increasing use of ionizing radiation in various aspects 
of human life, especially in cancer radiotherapy, food pre- 
servation, agriculture, industry, and power generation, 
means that there is a need to develop effective and non- 
toxic radioprotective agents. The currently available agents 
are associated with many drawbacks, including high cost, 
side effects and toxicity, and people have therefore started 
to investigate the anti-radiation properties of natural prod-
ucts. We have isolated a series of active ingredients from 
natural anti-radiation substances, such as polysaccharides 
[1–6], flavonoids [7–11], polyphenols [12–14], saponins 
[15–18], alkaloids [19,20], and peptide compounds [21,22].  
Gui-Pi-Wan and Gui-Pi-Tang contain the same drugs, 
but in different dosage forms. The “Ji Sheng Formula” for 
Gui-Pi-Tang was written by Yonghe Yan in the Song Dy-
nasty, and consists of Astragalus membranaceus, licorice 
(broil), ginseng, Angelica, Chinese Atractylodes, wild ju-
jube, Radix aucklandiae, Radix polygalae and dried longan 
pulp. Yao et al. [23] observed the outcomes in 86 patients 
with advanced esophageal cancer who were treated with 
Gui-Pi-Tang combined with concurrent chemoradiation. 
Gui-PiTang reduced the radiotherapy- and chemotherapy- 
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induced damage to the bone marrow and immune function, 
protected the body’s immunity, improved the quality of life 
of cancer patients after radiotherapy and chemotherapy, and 
may also have had some inhibitory effect on tumor metasta-
sis. Li et al. [24] reported an overall improvement rate of 
88.3% in 40 patients with neutropenia after chemotherapy 
treated with Gui-Pi-Tang combined with Fu-zheng-he- ji. 
However, no study has yet reported on the radioprotective 
activity of its extract. The present study therefore focused 
on the use of Gui-Pi-Wan precipitate by water extraction 
and alcohol precipitation (PWA) as a radioprotective agent 
in experimental cell and animal models.  
Gui-Pi-Wan extracts were used to reduce the required 
dosage and to enhance drug efficacy. The screening of 6 
extracts of the classic Chinese herbal formula Gui-Pi-Wan 
for anti-radiation activities in this study will form the basis 
for further screening of components with radioprotective 
activities. 
1  Materials and methods 
1.1  Materials  
(i) Animals.  Male KM mice (4–6 weeks old, weighing 
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l8–22 g) were purchased from the Experimental Animal 
Center of Xinxiang Medical University. Animals were 
housed at 10 per cage with ad libitum access to water and 
food pellets. 
(ii) Drugs and reagents.  Gui-Pi-Wan was manufactured 
by Wanxi Pharmaceutical Co., Ltd (Henan, China; product 
batch number 100903, production date 10.09.10); Cell 
Counting Kit-8 (CCK-8) was manufactured by Dojindo 
Laboratories (Kumamoto, Japan); “523” was obtained from 
Institute of Radiation Medicine (Beijing, China); Binding 
buffer was from an Annexin V-FITC apoptosis detection kit 
(Baosai Biotechnology Co., Ltd, China). 
(iii) Cell culture.  V79 Chinese hamster lung fibroblast 
cells were cultured adherently in DMEM medium contain-
ing 10% fetal bovine serum, 100 U/mL penicillin and 100 
U/mL streptomycin at 37°C in a humidified atmosphere of 
5% CO2. 
1.2  Preparation of Gui-Pi-Wan extracts 
(i) Preparation of water extract (WE).  Gui-Pi-Wan rough 
powder was extracted using 10 times the amount of boiling 
water. The extract was filtered through four layers of gauze. 
The entire process was repeated twice. The combined fil-
trate was centrifuged at 2000 r/min for 20 min, and concen-
trated under reduced pressure. Half of the liquid obtained 
was vacuum evaporated to produce a powder, which was 
redissolved in water just before oral administration. 
(ii) Preparation of supernatant by water extraction and 
alcohol precipitation (SWA).  The remaining half of the 
concentrated solution was cooled to room temperature and 
mixed with alcohol to an alcohol content of 70%. The mix-
ture was refrigerated for 24 h, filtered, concentrated, and 
vacuum evaporated to produce a powder, which was redis-
solved in water just before oral administration.   
(iii) Preparation of PWA.  Filtered sediment from Sec-
tion 1.2 (ii) was vacuum evaporated to produce a powder, 
which was redissolved in water just before oral administra-
tion.   
(iv) Preparation of ethanol extracts (EE).  Gui-Pi-Wan 
rough powder was extracted using 10 times the amount of 
70% ethanol, and the extract was filtered through four lay-
ers of gauze. The entire process was repeated twice. The 
combined filtrate was centrifuged at 2000 r/min for 20 min, 
and concentrated under reduced pressure. Half of the liquid 
obtained was vacuum evaporated to produce a powder, 
which was redissolved in water just before oral administra-
tion. 
(v) Preparation of supernatant by alcohol extraction and 
water precipitation (SAW).  The other half of the concen-
trated solution of ethanol extract was cooled to room tem-
perature and mixed with an appropriate amount of water. 
The mixture was refrigerated for 24 h, filtered, concen-
trated, and vacuum evaporated to produce a powder, which 
was redissolved in water just before oral administration. 
(vi) Preparation of precipitate by alcohol extraction and 
water precipitation (PAW).  Filtered sediment from (v) 
was vacuum evaporated to produce a powder, which was 
redissolved in water just before oral administration.   
1.3  Irradiation 
Cells were irradiated at room temperature with 60Co γ-rays 
at a dose rate of 227.7 cGy/min for a total dose of 5 Gy. The 
animals were restrained in holders and exposed to 8 Gy to-
tal-body 60Co γ radiation at a dose rate of 228.27 cGy/min to 
determine their 30-d survival rate. 
1.4  Radioprotective effects of extracts on V79 cells  
V79 cells (1×105 cells/mL) in logarithmic growth phase 
were seeded in 96-well plates containing 100 μL/well of 
drug at a final concentration of 1000 μg/mL (referred to as 
the drug groups). The drug groups were compared with 
control unirradiated cells and with irradiated, untreated 
cells. After 24 h, cells were irradiated with 60Co at a dose of 
5 Gy. CCK-8 solution (10 μL) was added to each well at 24 
h after irradiation. The absorbance of each well at 490 nm 
was determined after a further 4 h, using a multifunctional 
microplate reader [25].  
1.5  Radioprotective effects of different concentrations  
of PWA in V79 cells   
V79 cells (1×105 cells/mL) in logarithmic growth phase 
were seeded in 96-well plates containing 100 μL/well of 
drug at final drug concentrations of 1000, 500, 100, 50, or 
25 μg/mL (referred to as the drug groups). These were com-
pared with control unirradiated cells and with irradiated, 
untreated cells. After 24 h, cells were irradiated with 60Co at 
a dose of 5 Gy. CCK-8 solution (10 μL) was added to each 
well at 24 h after irradiation. The absorbance of each well 
was determined after a further 4 h, using a multifunctional 
microplate reader at 490 nm.  
1.6  Detection of apoptosis by Annexin V-fluorescein 
isothiocyanate (FITC)/propidium iodide (PI)  
double-staining method 
V79 cells (1×106 cells) in logarithmic growth phase were 
seeded in 6-well culture plates at a drug concentration of 
1000 μg/mL, according to the results of the experimental 
screening. After 24 h, cells were irradiated with 60Co at a 
dose of 5 Gy. Cells from the normal (unirradiated), irradi-
ated (untreated), and drug groups were collected at 24 h 
after irradiation and centrifuged at 1000 r/min for 10 min. 
The supernatant was removed, and cells were resuspended 
in 200 μL binding buffer after washing twice with pre- 
cooled phosphate-buffered saline. Annexin V-FITC 10 μL 
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was added to the cells. The cell suspension was gently 
mixed and incubated in the dark for 15 min at room tem-
perature. A total of 300 μL binding buffer and 5 μL PI were 
added, and the samples were analyzed by flow cytometry. 
1.7  Determination of 30-d survival rate 
Mice adapted to the environment were divided into normal 
(unirradiated), irradiated (untreated), positive control 
(treated with the known radioprotective agent “523”), and 
drug treatment groups. All drugs were administered orally. 
Mice in the normal and irradiation groups were given dis-
tilled water, and mice in the treatment groups received the 
appropriate drugs, as indicated in Table 1. All mice were 
observed for 30 d after irradiation. 
1.8  Statistical analysis 
Data were expressed as mean ± standard deviation (SD). 
The significance of differences between mean values for 
groups were analyzed using SPSS-16 (IBM, USA). The 
means of the treated groups were compared with those of 
the radiation-alone and unirradiated groups. A value of P < 
0.05 was considered to be statistically significant. 
2  Results  
2.1  Radioprotective effects of Gui-Pi-Wan extracts in  
V79 cells  
The effects of 6 different extracts of Gui-Pi-Wan (1000 
μg/mL) in V79 cells were tested. The survival rates at 24 h 
after irradiation are shown in Figure 1. PWA significantly 
improved the survival rate of irradiated cells, while the 
other extracts had negative effects on cell survival.  
2.2  Radioprotective effects of different concentrations  
of PWA in V79 cells   
The effects of different concentrations of PWA on the sur-
vival of V79 cells were examined. The survival rates at 24 h 
after irradiation are shown in Figure 2. The survival rates of 
the irradiated cells gradually increased with increasing con-
centrations of PWA. The survival rate was highest at a con-
centration of 1000 μg/mL, and this was therefore recom-
mended as the final concentration.  




Positive drug dose  
(agent “523”) 






Before irradiation 6 24 h; 5 mg/kg 




24 h; 2.5 mg/kg +  
within 3 h; 2.5 mg/kg 
8 500 
 
2.3  Detection of apoptosis by Annexin V-FITC/PI  
double-staining method 
The effects of the 6 different extracts of Gui-Pi-Wan on 
apoptosis were investigated. The apoptosis rates at 24 h 
after irradiation are shown in Figure 3. Irradiation increased 
the apoptosis rate to 40%, while pretreatment with PWA 
before 5 Gy irradiation significantly reduced the rate of 
apoptosis to 10%, compared with the irradiation group. The 
other extracts had no effect on the apoptosis rate. 
2.4  Observation of 30-d survival rate in mice 
The 30-d survival rates of mice are shown in Figure 4. Pre-
treatment with PWA improved the survival rate by 30%, 
compared with untreated irradiated animals. The survival 
rates in the groups treated with the other five extracts were 
lower than that in the untreated irradiation group. PWA 
therefore demonstrated a radioprotective function, while the 
other five extracts had negative effects in terms of radiation 
 
Figure 1  Survival rates of V79 cells treated with 6 different extracts of 
Gui-Pi-Wan. ##, P < 0.01 compared with irradiation alone. 
 
Figure 2  Survival rates of V79 cells treated with PWA. #, P < 0.05 com-
pared with irradiation alone; ##, P < 0.01 compared with irradiation alone; 
*, P < 0.01 compared with normal. 
 
Figure 3  Apoptosis rates in V79 cells after 24-h irradiation. (a) Unirradi-
ated group; (b) irradiation group; (c) pretreatment with PWA before irra-
diation (P < 0.01 compared with irradiation group). 
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protection. Administration of PWA after irradiation resulted 
in a survival rate of 10%, compared with 30% in untreated 
irradiated animals. PWA administered before and after irra-
diation resulted in a survival rate of 20% compared with 
40% in untreated irradiated animals. These results indicate 
that pretreatment with PWA is needed to realize its radio-
protective activity. 
3  Discussion and conclusions 
Exposure to ionizing radiation significantly decreased cell 
survival and increased apoptosis rates in irradiated cells in 
dose-dependent manners. PWA at a dose of 1000 μg/mL 
significantly prevented cell damage (P < 0.01). Similarly, 
exposure of mice to radiation at 8 Gy also had adverse ef-
fects, and pretreatment with PWA increased the survival 
rate to 70%, compared with 40% in the untreated irradiation 
group. Although PWA was based on the WE of Gui-Pi- 
Wan, PWA showed good anti-radiation efficacy, while WE 
and the other four extracts had negative radioprotective ef-
fects. Overall, these results suggest that further studies are 
needed to investigate the potent radioprotective effects of 
PWA. 
PWA contains ingredients including Astragalus polyose, 
and Atractylodes, Angelica, and Poria cocos polysaccha-
rides. The polysaccharide content of PWA determined by 
UV spectrophotometry was 83%. Previous studies have 
shown that the active polysaccharide ingredients in natural 
medicines are beneficial in resisting irradiation; e.g., Rieh et 
al. [26] found that the administration of lipopolysaccharide 
before irradiation protected the bone marrow and small in-
testine. Jiang et al. [27] found that Astragalus polyose sig-
nificantly reduced liver lipid peroxidase levels in irradiated 
mice, and significantly increased superoxide dismutase and 
catalase activities, in association with promotion of 
free-radical scavenging, inhibition or blocking of lipid per-
oxidation, and increased antioxidant capacity. Optimum 
protection by these natural ingredients can be achieved at 
non-toxic concentrations, giving them an advantage over 
thiol tissue-protective agents, such as amifostine, that are 
currently used during cancer radiotherapy. 
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